Form 4 for RNXT RenovoRx, Inc.
Accepted 2026-03-27 00:00:00 ET · period of report 2026-03-25 · accession 0001493152-26-013083 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-27 | 2026-03-25 | RNXT | VOLL MARK | CFO | A - Grant | $0.00 | +12.4K | 37.4K | +50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-25 | A | A | 12,380 | $0.00 | 37,380 | D | — | — | (F1) The reported transaction involved the Reporting Person's receipt of a grant of 12,380 restricted stock units for his service as a consultant of the Issuer for January 2026. |